NATALYA KORNEYEVA: Open Payments
NPI 1871169847 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,913 in 44 payments from 18 companies in 2025. Trend: 2023 $798 · 2024 $1,836 · 2025 $3,913
Food & beverage: $3,895Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $976 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $380 |
| Novo Nordisk Inc | 4 | $376 |
| Insmed, Inc. | 4 | $267 |
| Otsuka America Pharmaceutical, Inc. | 4 | $251 |
| Lilly USA, LLC | 2 | $227 |
| Amgen Inc. | 4 | $165 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Astellas Pharma US Inc | 1 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $139 |
Products named: BREZTRI, CAPLYTA, REXULTI, Arikayce, Ozempic, AIRSUPRA, REZDIFFRA, EVENITY.
Industry payments across FL — which companies pay providers there.
